CLINICAL-PHARMACOLOGY OF RU-486 - AN ANTIPROGESTIN AND ANTIGLUCOCORTICOID

被引:76
作者
SPITZ, IM
BARDIN, CW
机构
[1] Center for Biomedical Research, The Population Council, New York, NY 10021
基金
美国安德鲁·梅隆基金会;
关键词
RU-486; MIFEPRISTONE; ANTIGLUCOCORTICOID; ANTIPROGESTIN; ABORTION INDUCTION; PROSTAGLANDINS; OVULATION INHIBITION; MENSES INDUCTION; POSTCOITAL CONTRACEPTION; CERVICAL DILATATION;
D O I
10.1016/0010-7824(93)90133-R
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:403 / 444
页数:42
相关论文
共 143 条
  • [21] COUZINET B, 1990, FERTIL STERIL, V54, P1039
  • [22] TERMINATION OF EARLY-PREGNANCY BY THE PROGESTERONE ANTAGONIST RU-486 (MIFEPRISTONE)
    COUZINET, B
    LESTRAT, N
    ULMANN, A
    BAULIEU, EE
    SCHAISON, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (25) : 1565 - 1570
  • [23] VARIABLE EFFECTS OF RU-486 ON ENDOMETRIAL MAINTENANCE IN THE LUTEAL PHASE EXTENDED BY EXOGENOUS HCG
    CROXATTO, HB
    SALVATIERRA, AM
    CROXATTO, HD
    SPITZ, IM
    [J]. CLINICAL ENDOCRINOLOGY, 1989, 31 (01) : 15 - 23
  • [24] LATE LUTEAL PHASE ADMINISTRATION OF RU486 FOR 3 SUCCESSIVE CYCLES DOES NOT DISRUPT BLEEDING PATTERNS OR OVULATION
    CROXATTO, HB
    SALVATIERRA, AM
    ROMERO, C
    SPITZ, IM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (06) : 1272 - 1277
  • [25] EFFECTS OF CONTINUOUS TREATMENT WITH LOW-DOSE MIFEPRISTONE THROUGHOUT ONE MENSTRUAL-CYCLE
    CROXATTO, HB
    SALVATIERRA, AM
    CROXATTO, HD
    FUENTEALBA, B
    [J]. HUMAN REPRODUCTION, 1993, 8 (02) : 201 - 207
  • [26] PROSPECTS OF PGS IN POSTCONCEPTIONAL THERAPY
    CSAPO, AI
    [J]. PROSTAGLANDINS, 1973, 3 (03): : 245 - 289
  • [27] CONTRACEPTIVE POTENTIAL OF RU-486 BY OVULATION INHIBITION .3. PRELIMINARY-OBSERVATIONS ON ONCE WEEKLY ORAL-ADMINISTRATION
    DANFORTH, DR
    DUBOIS, C
    ULMANN, A
    BAULIEU, EE
    HODGEN, GD
    [J]. CONTRACEPTION, 1989, 40 (02) : 195 - 200
  • [28] DAS C, 1987, LANCET, V2, P599
  • [29] DERAEDT R, 1985, ANTIPROGESTIN STEROI, P123
  • [30] Deraedt R., 1985, ANTIPROGESTIN STEROI, P103